PAR-20-225 - Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases NOT-DA-22-048 NIDA, NCI, NIDCR Jan 9, 2023 Sep 9, 2025 R01, R21, DP2, DP1, K99/R00, K01, R36, K08, R15, K24

For technical issues E-mail OER Webmaster